Fact check
“The GAO believes the FDA should specify the criteria and process for determining a substance's "potential for abuse."”
Reasoning
The provided evidence quotes the GAO stating that the FDA should specify "the criteria and process for determining a substance's 'potential for abuse.'" This matches the claim exactly, confirming that the GAO holds this view.
On confidence: The claim is directly supported by a primary source excerpt from a Reason.com article citing the GAO report.
Important context
The GAO's recommendation is part of a broader critique of the Controlled Substances Act's lack of a statutory definition for 'potential for abuse,' highlighting challenges in drug scheduling.
Evidence
Supporting (1)
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
marijuana's abuse potential. The CSA "does not include a statutory definition of 'potential for abuse,'" the GAO notes, and "FDA officials told us that the lack of a written definition…presented challenges for determining the relative…
Limitations
The evidence is limited to a secondary news article summarizing the GAO report; the original GAO document was not directly accessed, so verification relies on the accuracy of the reporting. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:49 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum